Article

  • The EMBO Journal (2004) 23, 3164 - 3174
  • doi:10.1038/sj.emboj.7600315

Published online: 29 July 2004

ATR functions as a gene dosage-dependent tumor suppressor on a mismatch repair-deficient background

Yanan Fang1, Cheng-Chung Tsao2, Barbara K Goodman3, Ryohei Furumai1, Carlos A Tirado3, Robert T Abraham2 and Xiao-Fan Wang1

  1. Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC, USA
  2. Program in Signal Transduction Research, The Burnham Institute, La Jolla, CA, USA
  3. Department of Pathology, Duke University Medical Center, Durham, NC, USA

Correspondence to:

Robert T Abraham, Program in Signal Transduction Research, Cancer Research Center, The Burnham Institute, 10901 North Torrey Pines Road, La Jolla, CA 92037, USA. Tel.: +1 858 646 3182; Fax: +1 858 713 6274; E-mail: abraham@burnham.org

Xiao-Fan Wang, Department of Pharmacology and Cancer Biology, C218 Levine Science Research Center, Duke University Medical Center, Durham, NC 27710, USA. Tel.: +1 919 681 4861; Fax: +1 919 681 7152; E-mail: wang0011@mc.duke.edu

Received 7 April 2004; Accepted 17 June 2004


The ataxia-telangiectasia mutated and rad3-related (ATR) kinase orchestrates cellular responses to DNA damage and replication stress. Complete loss of ATR function leads to chromosomal instability and cell death. However, heterozygous ATR mutations are found in human cancers with microsatellite instability, suggesting that ATR haploinsufficiency contributes to tumorigenesis. To test this possibility, we generated human cell line and mouse model systems in which a single ATR allele was inactivated on a mismatch repair (MMR)-deficient background. Monoallelic ATR gene targeting in MLH1-deficient HCT 116 colon carcinoma cells resulted in hypersensitivity to genotoxic stress accompanied by dramatic increases in fragile site instability, and chromosomal amplifications and rearrangements. The ATR+/- HCT 116 cells also displayed compromised activation of Chk1, an important downstream target for ATR. In complementary studies, we demonstrated that mice bearing the same Atr+/-/Mlh1-/- genotype were highly prone to both embryonic lethality and early tumor development. These results demonstrate that MMR proteins and ATR functionally interact during the cellular response to genotoxic stress, and that ATR serves as a haploinsufficient tumor suppressor in MMR-deficient cells.

  • Keywords:

    • ATR,
    • mismatch repair,
    • MLH1,
    • tumor suppressor
Top

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated

REVIEWS

Drug discovery in the ubiquitin?proteasome system

Nature Reviews Drug Discovery Review (01 Jul 2006)

See all 13 matches for Reviews

NEWS AND VIEWS

Touching base

Nature Genetics News and Views (01 Mar 1997)